BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 8589706)

  • 1. Box BRCA1 tumour inhibition.
    Goodman L
    Nat Genet; 1996 Mar; 12(3):224. PubMed ID: 8589706
    [No Abstract]   [Full Text] [Related]  

  • 2. Transcriptional activation by BRCA1.
    Chapman MS; Verma IM
    Nature; 1996 Aug; 382(6593):678-9. PubMed ID: 8751436
    [No Abstract]   [Full Text] [Related]  

  • 3. Growth retardation and tumour inhibition by BRCA1.
    Holt JT; Thompson ME; Szabo C; Robinson-Benion C; Arteaga CL; King MC; Jensen RA
    Nat Genet; 1996 Mar; 12(3):298-302. PubMed ID: 8589721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [BRCA1 and cancer: a new lead].
    Larsen CJ
    Bull Cancer; 2000 Oct; 87(10):693-4. PubMed ID: 11185523
    [No Abstract]   [Full Text] [Related]  

  • 5. A breast/ovarian cancer patient with germline mutations in both BRCA1 and BRCA2.
    Ramus SJ; Friedman LS; Gayther SA; Ponder BA; Bobrow L; van der Looji M; Papp J; Olah E
    Nat Genet; 1997 Jan; 15(1):14-5. PubMed ID: 8988162
    [No Abstract]   [Full Text] [Related]  

  • 6. Mutations of the BRCA1 gene in human cancer.
    Xu CF; Solomon E
    Semin Cancer Biol; 1996 Feb; 7(1):33-40. PubMed ID: 8695765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BRCA1 is secreted and exhibits properties of a granin.
    Jensen RA; Thompson ME; Jetton TL; Szabo CI; van der Meer R; Helou B; Tronick SR; Page DL; King MC; Holt JT
    Nat Genet; 1996 Mar; 12(3):303-8. PubMed ID: 8589722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of apoptosis by the tumor suppressor protein BRCA1.
    Shao N; Chai YL; Shyam E; Reddy P; Rao VN
    Oncogene; 1996 Jul; 13(1):1-7. PubMed ID: 8700535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breaking down BRCA1.
    Nat Genet; 1994 Dec; 8(4):310. PubMed ID: 7894474
    [No Abstract]   [Full Text] [Related]  

  • 10. Are BRCA1- and BRCA2-associated breast cancers different?
    Offit K
    J Clin Oncol; 2000 Nov; 18(21 Suppl):104S-6S. PubMed ID: 11060336
    [No Abstract]   [Full Text] [Related]  

  • 11. Truncation at conserved terminal regions of BRCA1 protein is associated with highly proliferating hereditary breast cancers.
    Sobol H; Stoppa-Lyonnet D; Bressac-de-Paillerets B; Peyrat JP; Kerangueven F; Janin N; Noguchi T; Eisinger F; Guinebretiere JM; Jacquemier J; Birnbaum D
    Cancer Res; 1996 Jul; 56(14):3216-9. PubMed ID: 8764110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Brca1 and Brca2 proteins and tumor pathogenesis.
    Ingvarsson S
    Anticancer Res; 1999; 19(4B):2853-61. PubMed ID: 10652564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast cancer. What's mice got to do with it?
    Kinzler KW; Vogelstein B
    Nature; 1996 Aug; 382(6593):672. PubMed ID: 8751433
    [No Abstract]   [Full Text] [Related]  

  • 14. BRCA: the breast, ovarian, and other cancer genes.
    Boyd J
    Gynecol Oncol; 2001 Mar; 80(3):337-40. PubMed ID: 11263927
    [No Abstract]   [Full Text] [Related]  

  • 15. Antisense RNA to the putative tumor suppressor gene BRCA1 transforms mouse fibroblasts.
    Rao VN; Shao N; Ahmad M; Reddy ES
    Oncogene; 1996 Feb; 12(3):523-8. PubMed ID: 8637708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lessons learned from BRCA1 and BRCA2.
    Zheng L; Li S; Boyer TG; Lee WH
    Oncogene; 2000 Dec; 19(53):6159-75. PubMed ID: 11156530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic susceptibility to breast and ovarian cancer.
    Skolnick MH; Frank T; Shattuck-Eidens D; Tavtigian S
    Pathol Biol (Paris); 1997 Mar; 45(3):245-9. PubMed ID: 9296070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BRCA1 and BRCA2 mutations in Turkish breast/ovarian families and young breast cancer patients.
    Yazici H; Bitisik O; Akisik E; Cabioglu N; Saip P; Muslumanoglu M; Glendon G; Bengisu E; Ozbilen S; Dincer M; Turkmen S; Andrulis IL; Dalay N; Ozcelik H
    Br J Cancer; 2000 Sep; 83(6):737-42. PubMed ID: 10952777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of ten novel and 13 recurring BRCA1 and BRCA2 germline mutations in Italian breast and/or ovarian carcinoma patients. Mutations in brief no. 178. Online.
    De Benedetti VM; Radice P; Pasini B; Stagi L; Pensotti V; Mondini P; Manoukian S; Conti A; Spatti G; Rilke F; Pierotti MA
    Hum Mutat; 1998; 12(3):215. PubMed ID: 10660329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laboratory identification of hereditary risk of breast and ovarian cancer.
    Frank TS
    Curr Opin Biotechnol; 1999 Jun; 10(3):289-94. PubMed ID: 10361081
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.